Home » Topics » BioWorld Science

BioWorld Science
RSS

Gliatech obtains disappointing results from MRI reevaluation of ADCON-L

Oct. 17, 2001

Cilomilast does not affect esophageal motility or gut transit times in man

Oct. 17, 2001

BioVex and AstraZeneca establish gene target validation collaboration

Oct. 17, 2001

Development of beraprost for intermittent claudication expected to be dropped

Oct. 17, 2001

Ibex enzyme therapeutics acquired by BioMarin

Oct. 17, 2001

Introgen obtains exclusive worldwide license for tumor suppressor genes

Oct. 17, 2001

First-in-class antibiotic introduced in major European market

Oct. 17, 2001

Foradil now cleared for use in COPD in the U.S.

Oct. 17, 2001

GSK, UCSF and MMV establish collaborative project

Oct. 17, 2001

Health Canada approves enhanced labeling for Copaxone

Oct. 17, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...